UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Aryl Hydrocarbon Receptor is a Critical Regulator of Tissue Factor Stability and an Antithrombotic Target in Uremia

Journal of the American Society of Nephrology, 2016-01, Vol.27 (1), p.189-201

2016

Volltextzugriff (PDF)

Neglected Tropical Diseases: Drug Discovery and Development

1, 2019

Volltextzugriff (PDF)

Identification of cinnabarinic acid as a novel endogenous aryl hydrocarbon receptor ligand that drives IL-22 production

PloS one, 2014-02, Vol.9 (2), p.e87877

2014

Volltextzugriff (PDF)

Fexinidazole: A New Drug for African Sleeping Sickness on the Horizon

Trends in parasitology, 2018-03, Vol.34 (3), p.178-179

Pollastri, Michael P.

2018

Volltextzugriff (PDF)

The single cyclic nucleotide-specific phosphodiesterase of the intestinal parasite Giardia lamblia represents a potential drug target

PLoS neglected tropical diseases, 2017-09, Vol.11 (9), p.e0005891-e0005891

2017

Volltextzugriff (PDF)

Finding new collaboration models for enabling neglected tropical disease drug discovery

PLoS neglected tropical diseases, 2014-07, Vol.8 (7), p.e2866-e2866

2014

Volltextzugriff (PDF)

Anilinoquinoline based inhibitors of trypanosomatid proliferation

PLoS neglected tropical diseases, 2018-11, Vol.12 (11), p.e0006834-e0006834

2018

Volltextzugriff (PDF)

Identification and characterization of hundreds of potent and selective inhibitors of Trypanosoma brucei growth from a kinase-targeted library screening campaign

PLoS neglected tropical diseases, 2014-10, Vol.8 (10), p.e3253-e3253

2014

Volltextzugriff (PDF)

The susceptibility of trypanosomatid pathogens to PI3/mTOR kinase inhibitors affords a new opportunity for drug repurposing

PLoS neglected tropical diseases, 2011-08, Vol.5 (8), p.e1297

2011

Volltextzugriff (PDF)

Evaluation of a class of isatinoids identified from a high-throughput screen of human kinase inhibitors as anti-Sleeping Sickness agents

PLoS neglected tropical diseases, 2019-02, Vol.13 (2), p.e0007129-e0007129

2019

Volltextzugriff (PDF)

Repurposing strategies for tropical disease drug discovery

Bioorganic & medicinal chemistry letters, 2016-06, Vol.26 (11), p.2569-2576

2016

Volltextzugriff (PDF)

A target repurposing approach identifies N-myristoyltransferase as a new candidate drug target in filarial nematodes

PLoS neglected tropical diseases, 2014-09, Vol.8 (9), p.e3145-e3145

2014

Volltextzugriff (PDF)

Application of l‑Threonine Aldolase to on-DNA Reactions

Bioconjugate chemistry, 2021-09, Vol.32 (9), p.1973-1978

2021

Volltextzugriff (PDF)

Synthesis of a DNA-Encoded Macrocyclic Library Utilizing Intramolecular Benzimidazole Formation

Bioconjugate chemistry, 2023-06, Vol.34 (6), p.988-993

2023

Volltextzugriff (PDF)

Evaluation of pyrrolidine and pyrazolone derivatives as inhibitors of trypanosomal phosphodiesterase B1 (TbrPDEB1)

Tetrahedron letters, 2015-05, Vol.56 (21), p.2832-2835

2015

Volltextzugriff (PDF)

Kinases as Druggable Targets in Trypanosomatid Protozoan Parasites

Chemical reviews, 2014-11, Vol.114 (22), p.11280-11304

2014

Volltextzugriff (PDF)

Chemical Optimization of CBL0137 for Human African Trypanosomiasis Lead Drug Discovery

Journal of medicinal chemistry, 2023-02, Vol.66 (3), p.1972-1989

2023

Volltextzugriff (PDF)

Physiologic Targets and Modes of Action for CBL0137, a Lead for Human African Trypanosomiasis Drug Development

Molecular pharmacology, 2022-07, Vol.102 (1), p.1-16

2022

Volltextzugriff (PDF)

Calcium-Dependent Protein Kinase 5 Is Required for Release of Egress-Specific Organelles in Plasmodium falciparum

mBio, 2018-02, Vol.9 (1), p.e00130

2018

Volltextzugriff (PDF)

Medicinal Chemistry Optimization of a Diaminopurine Chemotype: Toward a Lead for Trypanosoma brucei Inhibitors

Journal of medicinal chemistry, 2020-09, Vol.63 (17), p.9912-9927

2020

Volltextzugriff (PDF)

Pharmacophore Identification and Structure–Activity Relationship Analysis of a Series of Substituted Azaindoles as Inhibitors of Trypanosoma brucei

Journal of medicinal chemistry, 2024-08, Vol.67 (16), p.13985-14006

2024

Volltextzugriff (PDF)

Protozoan Parasite Growth Inhibitors Discovered by Cross-Screening Yield Potent Scaffolds for Lead Discovery

Journal of medicinal chemistry, 2015-07, Vol.58 (14), p.5522-5537

2015

Volltextzugriff (PDF)

Hit-to-Lead Optimization of Benzoxazepinoindazoles As Human African Trypanosomiasis Therapeutics

Journal of medicinal chemistry, 2020-03, Vol.63 (5), p.2527-2546

2020

Volltextzugriff (PDF)

Kinase Scaffold Repurposing for Neglected Disease Drug Discovery: Discovery of an Efficacious, Lapatanib-Derived Lead Compound for Trypanosomiasis

Journal of medicinal chemistry, 2013-05, Vol.56 (10), p.3820-3832

2013

Volltextzugriff (PDF)

Target repurposing for neglected diseases

Future medicinal chemistry, 2011-08, Vol.3 (10), p.1307-1315

2011

Volltextzugriff (PDF)

1 – 25 von 136

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(133)

Publikationsform

Artikel
(115)
Buchkapitel
(20)
Bücher
(1)

Sprache

Englisch
(136)

Erscheinungsjahr

n.n

Thema

Science & Technology
(102)
Life Sciences & Biomedicine
(94)
Pharmacology & Pharmacy
(53)
Tropical Medicine
(48)
Humans
(47)
Infectious Diseases
(41)
Chemistry, Medicinal
(37)
Animals
(35)
Parasitology
(35)
Parasites
(33)
Tropical Diseases
(29)
Mice
(25)
Drug Discovery
(23)
Chemistry
(22)
Trypanosoma Brucei
(22)
Medicine And Health Sciences
(21)
Physical Sciences
(21)
Biology And Life Sciences
(19)
Trypanocidal Agents - Pharmacology
(19)
Trypanosoma Brucei Brucei - Drug Effects
(19)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The Aryl Hydrocarbon Receptor is a Critical Regulator of Tissue Factor Stability and an Antithrombotic Target in Uremia

Neglected Tropical Diseases: Drug Discovery and Development

Identification of cinnabarinic acid as a novel endogenous aryl hydrocarbon receptor ligand that drives IL-22 production

Fexinidazole: A New Drug for African Sleeping Sickness on the Horizon

The single cyclic nucleotide-specific phosphodiesterase of the intestinal parasite Giardia lamblia represents a potential drug target

Finding new collaboration models for enabling neglected tropical disease drug discovery

Anilinoquinoline based inhibitors of trypanosomatid proliferation

Identification and characterization of hundreds of potent and selective inhibitors of Trypanosoma brucei growth from a kinase-targeted library screening campaign

The susceptibility of trypanosomatid pathogens to PI3/mTOR kinase inhibitors affords a new opportunity for drug repurposing

Evaluation of a class of isatinoids identified from a high-throughput screen of human kinase inhibitors as anti-Sleeping Sickness agents

Repurposing strategies for tropical disease drug discovery

A target repurposing approach identifies N-myristoyltransferase as a new candidate drug target in filarial nematodes

Application of l‑Threonine Aldolase to on-DNA Reactions

Synthesis of a DNA-Encoded Macrocyclic Library Utilizing Intramolecular Benzimidazole Formation

Evaluation of pyrrolidine and pyrazolone derivatives as inhibitors of trypanosomal phosphodiesterase B1 (TbrPDEB1)

Kinases as Druggable Targets in Trypanosomatid Protozoan Parasites

Chemical Optimization of CBL0137 for Human African Trypanosomiasis Lead Drug Discovery

Physiologic Targets and Modes of Action for CBL0137, a Lead for Human African Trypanosomiasis Drug Development

Calcium-Dependent Protein Kinase 5 Is Required for Release of Egress-Specific Organelles in Plasmodium falciparum

Medicinal Chemistry Optimization of a Diaminopurine Chemotype: Toward a Lead for Trypanosoma brucei Inhibitors

Pharmacophore Identification and Structure–Activity Relationship Analysis of a Series of Substituted Azaindoles as Inhibitors of Trypanosoma brucei

Protozoan Parasite Growth Inhibitors Discovered by Cross-Screening Yield Potent Scaffolds for Lead Discovery

Hit-to-Lead Optimization of Benzoxazepinoindazoles As Human African Trypanosomiasis Therapeutics

Kinase Scaffold Repurposing for Neglected Disease Drug Discovery: Discovery of an Efficacious, Lapatanib-Derived Lead Compound for Trypanosomiasis

Target repurposing for neglected diseases

Suchergebnisse filtern